Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGVISOMANT for Hypopituitarism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where PEGVISOMANT was used for Hypopituitarism.

Most Reported Side Effects for PEGVISOMANT

Side Effect Reports % Deaths Hosp.
Off label use 460 15.3% 27 64
Drug ineffective 328 10.9% 2 32
Insulin-like growth factor increased 320 10.6% 2 43
Product dose omission issue 255 8.5% 2 36
Headache 244 8.1% 1 41
Fatigue 224 7.4% 6 38
Arthralgia 184 6.1% 1 31
Death 162 5.4% 162 11
Injection site pain 161 5.3% 1 23
Product use issue 158 5.2% 11 52
Diarrhoea 151 5.0% 1 39
Nausea 142 4.7% 0 45
Pain 121 4.0% 0 22
Malaise 114 3.8% 3 23
Needle issue 110 3.7% 0 18

Other Indications for PEGVISOMANT

Acromegaly (1,911) Gigantism (252) Pituitary tumour (82) Product used for unknown indication (73) Pituitary tumour benign (48) Insulin-like growth factor increased (46) Hypothalamo-pituitary disorder (41) Neoplasm (27) Blood growth hormone increased (21) Brain neoplasm (20)

Other Drugs Used for Hypopituitarism

SOMATROPIN (5,842) LONAPEGSOMATROPIN-TCGD (225) HYDROCORTISONE (208) LEVOTHYROXINE (84) TESTOSTERONE (67) DESMOPRESSIN (53) SOMATROGON-GHLA (38) DUPILUMAB (29) SOMATREM (22) NUTROPIN AQ (20)

Related Pages

PEGVISOMANT Full Profile All Hypopituitarism Drugs PEGVISOMANT Demographics PEGVISOMANT Timeline